India Globalization Capital Inc. and investors who say it misled them about plans for a sugar-free cannabis drink can move forward with their $1 million settlement, a federal judge in Maryland said.
The proposed settlement class covers everyone who acquired the biopharmaceutical company’s publicly traded common stock from Sept. 26, 2018, to and including Oct. 26, 2018, with exceptions for those with other ties to IGC, the U.S. District Court for the District of Maryland said.
Judge Paul W. Grimm previously rejected the company’s bid to throw out the case. The investors alleged enough facts to “create a plausible ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.